<?xml version="1.0" encoding="UTF-8"?>
<ref id="B106-molecules-25-05905">
 <label>106.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bentz</surname>
    <given-names>G.L.</given-names>
   </name>
   <name>
    <surname>Lowrey</surname>
    <given-names>A.J.</given-names>
   </name>
   <name>
    <surname>Horne</surname>
    <given-names>D.C.</given-names>
   </name>
   <name>
    <surname>Nguyen</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Satterfield</surname>
    <given-names>A.R.</given-names>
   </name>
   <name>
    <surname>Ross</surname>
    <given-names>T.D.</given-names>
   </name>
   <name>
    <surname>Harrod</surname>
    <given-names>A.E.</given-names>
   </name>
   <name>
    <surname>Uchakina</surname>
    <given-names>O.N.</given-names>
   </name>
   <name>
    <surname>McKallip</surname>
    <given-names>R.J.</given-names>
   </name>
  </person-group>
  <article-title>Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency</article-title>
  <source>PLoS ONE</source>
  <year>2019</year>
  <volume>14</volume>
  <elocation-id>e0217578</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0217578</pub-id>
  <pub-id pub-id-type="pmid">31125383</pub-id>
 </element-citation>
</ref>
